Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats

Dublin Core

Title

Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats

Subject

Health & Wellness

Description

"
The aim of this experiment was to evaluate the anti-inflammatory potential of the Biofield Energy Treated Proprietary Test Formulation and Biofield Energy Treatment per se to the animals on Cecal Slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) model in Sprague Dawley rats. The parameters studies in this experiment includes tumour necrosis factor alpha (TNF-α), interleukin-6 (IL-6), macrophage inflammatory protein-2 (MIP-2), matrix metallopeptidase 9 (MMP-9), fibrin degradation products (FDP), Substance P, inducible nitric oxide synthase (iNOS) were analysed using ELISA assay. A test formulation was formulated including minerals (magnesium, zinc, calcium, selenium, and iron), vitamins (ascorbic acid, pyridoxine HCl, vitamin E, cyanocobalamin, and cholecalciferol), Panax ginseng extract, β-carotene, and cannabidiol isolate. The constituents of the test formulation were divided into two parts; one section was defined as the untreated test formulation, while the other portion of the test formulation and three group of animals received Biofield Energy Healing Treatment (prayer) remotely for about 3 minutes by a renowned Biofield Energy Healer, Mr. Mahendra Kumar Trivedi. The level of TNF-α was significantly (p≤0.001) decreased by 46.94% and 55.91% in the G6 (Cecal Slurry, LPS and E. coli along with Biofield Energy Treatment per se to animals from day -15) group as compared to the disease control group (G2) and the untreated test formulation (G4), respectively. The level of IL-6 was significantly (p≤0.001) reduced by 51.44% and 42.92% in the G6 group as compared to the disease control (G2) group and untreated test formulation group, respectively. The level of MIP-2 was significantly reduced by 21.52% and 31.54% (p≤0.001) in the G6 group as compared to the G2 and G4 groups, respectively. The level of MMP-9 was significantly decreased by 40.13% (p≤0.001) and 20.92% in the G6 and G8 groups, respectively as compared to the G2 group. Moreover, the level of FDP was significantly (p≤0.001) decreased by 38.22% and 50.53% in the G6 group as compared to the G2 and G4 groups, respectively. The level of substance P was significantly (p≤0.001) decreased by 36.96% and 38.20% in the G6 group as compared to the G2 and G4, groups, respectively. The level of iNOS was significantly (p≤0.001) decreased by 35.41% in the G6 group as compared to the G4 group. Overall, the data suggested the anti-inflammatory potentials of the Biofield Energy Treated test formulation and Biofield Energy Treatment per se along with preventive measure on the animal with respect to various inflammatory conditions that might be beneficial various types of systemic inflammatory disorders specially sepsis, trauma, septic shock or any types of injuries. Therefore, the results showed the significant slowdown the inflammation-related disease progression and its complications/symptoms in the preventive Biofield Energy Treatment group per se group (G6) comparatively with the disease control group."

Creator

Trivedi MK, Branton A, Trivedi D and Jana S

Publisher

Medwin Publishers

Date

22-Jul-2021

Contributor

[no text]

Rights

[no text]

Relation

[no text]

Format

[no text]

Language

English

Type

Journal Article

Identifier

[no text]

Coverage

[no text]

Citation

Trivedi MK, Branton A, Trivedi D and Jana S , “Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats,” Mahendra Trivedi, accessed April 28, 2024, https://mahendratrivedi.omeka.net/items/show/517.